Evaluation of the Clinical Benefit of a Transmitter for Contralateral Routing of Signals (CROS)

Stopped This clinical trial has been early terminated due to recruiting issues of the calculated sample size.

Conditions

• Hearing Loss

Interventions

• OTHER: BiCROS fitting
• OTHER: Monaural fitting
• OTHER: Unaided condition
• OTHER: CROS baseline

Sponsor

Sonova AG